Neurologic Manifestations of HIV Infection
Ann Int Med 121:769-785, Simpson,D.M.&Tagliati,M., 1994
Myopathies Assoc with HIV and Zidovudine:Can Their Effects be Distinguished?
Neurol 43:971-976, Simpson,D.M.,et al, 1993
AIDS and the Nervous System
JAMA 261:2396-2399, Dalakas,M.,et al, 1989
Rhabdomyolysis: An Evaluation of 475 Hospitalized Patients
Medicine 84:377-385, Melli,G.,et al, 2005
Peripheral Neuropathy in HIV Infected Patients with the Diffuse Infiltrative Lymphocytosis Syndrome
Ann Neurol 41:438-445, Moulignier,A.,et al, 1997
Acute Diffuse Leukoencephalitis HIV-1 Infection
JNNP 57:105-107, Luer,W.,et al, 1994
Human Immunodeficiency Virus Type 1 Infection and Myopathy:Clinical Relevance of Zidovudine Therapy
Ann Neurol 34:206-211, Grau,J.M.,et al, 1993
Depletion of Muscle Mitochondrial DNA in AIDS Patients with Zidovudine-Induced Myopathy
Lancet 337:508-510, Arnaudo,E.,et al, 1991
Acquired Immunodeficiency Syndrome, CSF Before & During Long-Term Oral Zidovudine Therapy
Arch Neurol 48:695-699, Tartaglione,T.A.,et al, 1991
Prognosis in AZT Myopathy
Neurol 41:1181-1184, Chalmers,A.C.,et al, 1991
Myopathy in Human Immunodeficiency Virus-Infected Children Receiving Long-Term Zidovudine Therapy
J Pediatr 119:152-155, Walter,E.B.,et al, 1991
Zidovudine Myopathy:A Distinctive Disorder Associated with Mitochondrial Dysfunction
Ann Neurol 29:606-614, Mhiri,C.,et al, 1991
Mitochondrial Myopathy Caused by Long-Term Ziduvudine Therapy
NEJM 322:1098-1105, Dalakas,M.C.,et al, 1990
Myopathy with Human Immunodeficiency Virus Type I (HIV-1) Infection:HIV-1 or Zidovudine?
Ann Int Med 113:492-493, Till,M.&MacDonell,K., 1990
Zidovudine-Associated Myopathy
Am J Med 86:814-818, Gertner,E.,et al, 1989
Severe Polymyositis-Like Syndrome Associated with Zidovudine Therapy of AIDS & ARC
NEJM 318:708, Bessen,L.J.,et al, 1988